• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体内数据,开发并验证洛匹那韦(一种水溶性差的药物)软胶囊溶出度试验。

Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data.

作者信息

Donato Eliane Maria, Martins Laura Alegria, Fröehlich Pedro Eduardo, Bergold Ana Maria

机构信息

Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul., Av. Ipiranga 2752, 90610-000 Porto Alegre, RS, Brazil.

出版信息

J Pharm Biomed Anal. 2008 Jul 15;47(3):547-52. doi: 10.1016/j.jpba.2008.02.014. Epub 2008 Feb 26.

DOI:10.1016/j.jpba.2008.02.014
PMID:18403160
Abstract

The objective of the present study was to develop and validate a dissolution test for lopinavir soft gel capsules (Kaletra), using a simulated absorption profile based on in vivo data. Different conditions such as surfactant concentration, apparatus and rotation speed were evaluated. In vivo release profiles were obtained from the literature. The fraction (and percentage) of dose absorbed (FA) was calculated by using Wagner-Nelson method. The best in vitro dissolution profile was obtained using Apparatus 2 (paddle) at 25 rpm, 1000 ml of medium with 2.3% of sodium lauryl sulfate and pH 6.0. Under these conditions a level-A in vitro-in vivo correlation (IVIVC) was obtained (r = 0.997). The in vitro dissolution samples were analyzed using a HPLC method and the validation was performed according to USP protocol. The method showed accuracy, precision, linearity and specificity within the acceptable range. Both the HPLC method and the in vitro dissolution method were validated and could be used to evaluate the release profile of lopinavir soft gel capsules.

摘要

本研究的目的是基于体内数据开发并验证洛匹那韦软胶囊(克力芝)的溶出度试验,采用模拟吸收曲线。评估了不同条件,如表面活性剂浓度、装置和转速。从文献中获取体内释放曲线。采用Wagner-Nelson法计算吸收剂量分数(FA)及其百分比。使用桨法装置2,转速25 rpm,含2.3%十二烷基硫酸钠且pH值为6.0的1000 ml介质,获得了最佳的体外溶出曲线。在这些条件下,获得了A级体外-体内相关性(IVIVC)(r = 0.997)。采用HPLC法分析体外溶出样品,并根据美国药典规程进行验证。该方法在可接受范围内显示出准确性、精密度、线性和特异性。HPLC法和体外溶出度方法均经过验证,可用于评估洛匹那韦软胶囊的释放曲线。

相似文献

1
Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data.基于体内数据,开发并验证洛匹那韦(一种水溶性差的药物)软胶囊溶出度试验。
J Pharm Biomed Anal. 2008 Jul 15;47(3):547-52. doi: 10.1016/j.jpba.2008.02.014. Epub 2008 Feb 26.
2
Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data.基于体内数据的利托那韦软胶囊溶出度试验的开发与验证
Int J Pharm. 2007 Jun 29;338(1-2):119-24. doi: 10.1016/j.ijpharm.2007.01.036. Epub 2007 Jan 31.
3
Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.基于体内数据的福沙那韦片溶出度区分方法的建立与验证。
J Pharm Biomed Anal. 2011 Feb 20;54(3):439-44. doi: 10.1016/j.jpba.2010.09.004. Epub 2010 Sep 15.
4
Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.盐酸非索非那定胶囊和包衣片溶出度试验的开发与验证
J Pharm Pharm Sci. 2005 Aug 11;8(2):289-98.
5
Designing biorelevant dissolution tests for lipid formulations: case example--lipid suspension of RZ-50.设计脂质制剂的生物相关性溶出度试验:实例——RZ-50脂质混悬液
Eur J Pharm Biopharm. 2008 Jun;69(2):776-85. doi: 10.1016/j.ejpb.2007.12.010. Epub 2007 Dec 23.
6
Investigation on different levels of in vitro-in vivo correlation: gemfibrozil immediate release capsule.
Biopharm Drug Dispos. 2008 Sep;29(6):349-55. doi: 10.1002/bdd.620.
7
Development of a discriminating in vitro dissolution method for a poorly soluble NO-donating selective cyclooxygenase-2 inhibitor.一种难溶性一氧化氮供体型选择性环氧化酶-2抑制剂体外溶出度区分方法的开发。
J Pharm Biomed Anal. 2008 May 12;47(1):16-22. doi: 10.1016/j.jpba.2007.12.025. Epub 2007 Dec 23.
8
In vitro-in vivo correlation for nevirapine extended release tablets.奈韦拉平缓释片的体外-体内相关性研究。
Biopharm Drug Dispos. 2009 Dec;30(9):542-50. doi: 10.1002/bdd.691.
9
Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.使用生物等效的盐酸多西环素药品对比世界卫生组织(WHO)和美国食品药品监督管理局(US FDA)的生物豁免溶出度测试条件。
J Pharm Pharmacol. 2009 Mar;61(3):331-7. doi: 10.1211/jpp/61.03.0007.
10
Validation of an HPLC-MS method for rociverine tablet dissolution analysis.用于罗西维林片溶出度分析的高效液相色谱-质谱法的验证
J Pharm Biomed Anal. 2008 Jun 9;47(2):422-8. doi: 10.1016/j.jpba.2008.01.009. Epub 2008 Jan 16.

引用本文的文献

1
In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug.通过选择性激光烧结对3D打印的无定形洛匹那韦微丸进行体外和体内测试:提高难溶性药物的生物利用度。
AAPS PharmSciTech. 2024 Jan 24;25(1):20. doi: 10.1208/s12249-023-02729-y.
2
Shell Formulation in Soft Gelatin Capsules: Design and Characterization.软胶囊的囊壳配方:设计与表征。
Adv Healthc Mater. 2024 Jan;13(1):e2302250. doi: 10.1002/adhm.202302250. Epub 2023 Oct 18.
3
Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption.
洛匹那韦-薄荷醇共晶体用于提高溶解速率和肠道吸收。
J Drug Deliv Sci Technol. 2022 Aug;74:103587. doi: 10.1016/j.jddst.2022.103587. Epub 2022 Jul 11.
4
Challenges of Dissolution Methods Development for Soft Gelatin Capsules.软胶囊溶出方法开发的挑战
Pharmaceutics. 2021 Feb 4;13(2):214. doi: 10.3390/pharmaceutics13020214.
5
Encapsulation Effect on the In Vitro Bioaccessibility of Sacha Inchi Oil ( L.) by Soft Capsules Composed of Gelatin and Cactus Mucilage Biopolymers.明胶和仙人掌黏液生物聚合物组成的软胶囊对印加果油体外生物可及性的包封作用
Polymers (Basel). 2020 Sep 2;12(9):1995. doi: 10.3390/polym12091995.
6
Formulation of a film-coated dutasteride tablet bioequivalent to a soft gelatin capsule (Avodart): Effect of γ-cyclodextrin and solubilizers.一种与软胶囊(Avodart)生物等效的薄膜包衣度他雄胺片的制剂:γ-环糊精和增溶剂的作用
Asian J Pharm Sci. 2019 May;14(3):313-320. doi: 10.1016/j.ajps.2018.08.007. Epub 2018 Oct 5.
7
Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.基于脂质的制剂的药代动力学方面及体外-体内相关性潜力。
Acta Pharm Sin B. 2014 Oct;4(5):333-49. doi: 10.1016/j.apsb.2014.09.001. Epub 2014 Oct 8.